GlassScriptPhysician profile
John Miles Mcclure, II
NPI 1427091123
$33,211.93
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $3,579 · 2021: $29K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22,916.67 | 2021 | |
| Esperion Therapeutics, INC. | $8,000.87 | 2020-2021 | |
| Cardiovascular Systems INC. | $430.82 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $239.78 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.19 | 2019-2021 | |
| Amarin Pharma, INC. | $221.82 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $192.82 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $149.06 | 2019-2021 | |
| Medtronic Vascular, INC. | $111.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $110.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $94.93 | 2019-2021 | |
| Lundbeck LLC | $85.61 | 2019-2021 | |
| Intact Vascular, INC. | $85.27 | 2019 | |
| Avinger INC. | $83.85 | 2019-2020 | |
| Boston Scientific Corporation | $60.68 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $57.22 | 2019 | |
| Merck Sharp & Dohme LLC | $42.93 | 2021 | |
| Janssen Biotech, INC. | $27.06 | 2019 | |
| Bardy Diagnostics, INC. | $24.26 | 2020-2021 | |
| Medtronic Minimed, INC. | $17.15 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.44 | 2020 | |
| Cardiva Medical, INC. | $12.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.